How Much Does Vision Therapy Cost, and Why It Varies
One of the most common questions we hear is, “How much does vision therapy cost?” The honest answer is that there is no single flat price, because vision therapy is not one product. Every program is built around the patient’s findings, symptoms, goals, session length and how much support they need between visits.
At Vision & Learning Center, binocular vision and visual processing programs usually run 18 to 24 weeks (amblyopia, strabismus and brain injury programs often take longer), with one, two or three sessions per week. Sessions typically range from $110 to $200, depending on session length and program structure. We offer 30-minute and 45-minute sessions, chosen by age, symptoms, stamina and treatment needs.
Key takeaways
- Most sessions run $110-$200; binocular vision and visual processing programs usually run 18-24 weeks (amblyopia, strabismus and brain injury take longer) at 1-3 visits per week. The total depends far more on program length and intensity than on the per-session fee.
- The research programs give you a benchmark: the office-based arm of the Convergence Insufficiency Treatment Trial used a weekly 60-minute office visit for 12 weeks plus 15 minutes of home therapy, 5 days a week (CITT Study Group, 2008).
- The evidence is condition-specific. It is strongest for symptomatic convergence insufficiency in children, weaker in adults, and negative for reading scores (CITT-ART, 2019).
- Home practice is not a formality. It is part of the protocol that was actually tested, and adherence is where programs quietly fail.
- We are out-of-network. Some families get partial reimbursement; many use HSA/FSA, CareCredit, payment plans or our monthly scholarships.
The short answer
If you want a general idea before committing: the cost of vision therapy depends on how many sessions are recommended, how long each session lasts, and how many weeks the program runs.
Some patients do best on a lighter weekly schedule with strong home follow-through. Others need a more intensive in-office plan. Both are vision therapy. They are simply not the same program, and they will not cost the same.
What a research-grade program actually looks like
This is the most useful comparison tool most families never get, so here it is.
The Convergence Insufficiency Treatment Trial randomized 221 children aged 9 to 17. The children assigned to office-based vergence and accommodative therapy attended a weekly 60-minute in-office visit for 12 weeks, supervised the whole time by a trained therapist, and were prescribed 15 minutes of home therapy a day, 5 days a week (CITT Study Group, 2008). The follow-on CITT-ART trial ran the same office-based therapy for 16 weeks (CITT-ART Investigator Group, 2019).
So roughly 12 to 16 supervised office hours, plus 15 to 20 hours of home work, is what the published trials paid for in children with that one diagnosis. Our programs range wider because our patients are not all 9- to 17-year-olds with isolated convergence insufficiency, but if a program you are quoted is far shorter or dramatically longer than that benchmark, it is fair to ask why.
What changes the price
1. Session length
We offer 30-minute and 45-minute sessions. Shorter sessions often suit younger children or patients with lower stamina; longer sessions may fit better depending on age, attention, symptoms and goals. Session length changes the structure of care, so it changes the cost.
2. How many visits per week
Most patients come one to three times per week. Once weekly costs less in office fees than three times weekly. Frequency is not chosen at random. It follows the severity of the problem, the goals of therapy, and how much reinforcement can realistically happen between visits.
3. How long the full program runs
Binocular vision and visual processing programs usually run about 18 to 24 weeks; amblyopia, strabismus and brain injury programs often take longer. Some patients move faster; some need more time. Severity, complexity, consistency and goals all move that number, and the number of weeks is the single biggest driver of total cost.
4. Home practice, and the adherence problem
This is the factor families underestimate most.
Every trial that produced good results paired office visits with prescribed home work. When home follow-through is strong, a patient may not need the same in-office intensity as someone who cannot do it. When home support is limited, more frequent office visits are often the honest recommendation instead, and that costs more.
Adherence is a real risk, not a talking point. In a large pediatric trial of a prescribed home treatment for amblyopia, only 22.2% of children completed more than 75% of what was prescribed (Holmes et al., 2016). That was a different condition and a different treatment, but it is the clearest published picture of how far home work drifts from the plan when nobody is watching.
There is a counterpoint worth knowing. A 176-patient trial in India found that home pencil push-ups, with compliance tracked by logbook, produced similar improvement in near point of convergence and symptoms to office-based orthoptic therapy, though office therapy produced better fusional vergence (Singh et al., 2021). That trial had no placebo group and used a different office protocol, and it disagrees with CITT, where home pencil push-ups were no more effective than office-based placebo therapy (CITT Study Group, 2008). The American Academy of Ophthalmology’s 2021 review of this literature concluded that evidence is still insufficient to say whether home-based therapies work (Chang et al., 2021). We tell families both halves of that.
5. How the program itself is structured
Not every plan is organized the same way. One patient may be recommended a once-weekly 45-minute session with home support. Another needs shorter, more frequent visits. Some programs include progress checks and re-evaluations at intervals. The cost is tied to the structure of the plan, not to the label “vision therapy.”
Is it worth it? That depends on the diagnosis
“Worth it” is not a single answer, because the evidence is condition-specific. It is strongest for symptomatic convergence insufficiency in children, where a Cochrane network meta-analysis of 12 trials and 1,289 participants found office-based vergence and accommodative therapy with home reinforcement about three times as likely as placebo to produce a successful outcome (Scheiman et al., 2020). It is weaker in adults, where 42% of treated patients met the symptom-elimination criteria versus 31% on placebo (Scheiman et al., 2005). And it is negative for reading scores: in CITT-ART, reading comprehension improved 3.7 points with therapy and 3.8 points with placebo (CITT-ART Investigator Group, 2019).
That is worth knowing before you spend anything, because it means the fee buys a well-supported treatment for some diagnoses and not for others. We lay out the full evidence, including where the professional bodies disagree, in does vision therapy actually work, and the week-by-week timeline in how long vision therapy takes.
Our clinical perspective at Vision & Learning Center. We do not sell vision therapy as a reading program or as a treatment for dyslexia or ADHD. What we treat are measurable eye-teaming, focusing and eye-movement problems that make near work uncomfortable, tiring or double. When those are present and symptomatic, the case for treatment is good and the outcome is measurable. When they are not, we tell you that and we do not recommend a therapy program.
Does insurance cover vision therapy?
Sometimes partially, but go in expecting variability.
We are an out-of-network practice, and payment is due at the time of service. Some patients can submit for reimbursement through out-of-network benefits, and we provide the documentation for that. Coverage depends entirely on the individual plan and is affected by deductibles, coinsurance, visit limits, exclusions and documentation requirements.
Before you begin, ask your insurer specifically about out-of-network benefits, pre-authorization, allowed amounts, visit limits and required documentation. Our cost and price page walks through the same checklist.
Can you use HSA or FSA funds?
In many cases, yes. Many patients use HSA or FSA funds for vision therapy when their plan permits it. Because plan rules vary, confirm eligibility with your benefits provider first.
What payment options do you offer?
- Payment is due at the time of service
- We accept major cards, checks, cash and CareCredit
- We offer structured payment plans, and can extend payments beyond the therapy timeline to keep monthly costs manageable
- CareCredit may offer no-interest promotional options and longer-term financing
- Families who pay in full may receive a 5-10% discount on the vision therapy session portion
- We award scholarships to two patients each month for families who need help covering therapy costs
- For eligible families we accept the Florida FES-UA scholarship (Family Empowerment Scholarship for Students with Unique Abilities, through Step Up For Students) under the terms listed on our pricing page
Why one program is not identical to another
Vision therapy is not priced like a single product because it is not a single product. It is a doctor-directed plan. Some children need shorter sessions and more parent-supported home work. Some teens and adults need therapy built around visual stamina, binocular coordination, screen-related symptoms or recovery from visual stress. Some patients progress quickly; others need a longer runway.
So when one family hears a different number than another, it does not mean one case is being overtreated. It means the program is being matched to the person in front of us. The first step is priced separately, as explained in what a developmental vision evaluation costs.

Cost questions worth asking before you pay for anything
Ask these of us, or of any practice:
- What is included in the per-session fee? Therapist time, equipment used in the office, home materials, progress checks - or only the session itself?
- What is billed separately, and when? The evaluation, re-evaluations, lenses, prisms, filters and take-home equipment are often priced apart from the sessions.
- What happens financially if the program runs long, or ends early? Ask how added weeks are billed, whether unused prepaid sessions are refunded, and how a payment plan adjusts.
A practice that answers all three in plain numbers has earned the fee. Our cost and price page and FAQ page cover more, and the clinical questions to ask - the diagnosis, the evidence behind it, and how progress will be measured - are listed in how long vision therapy takes.
The next step
If you are wondering what vision therapy will cost, the most honest answer is that it depends on the program you actually need — and nobody can tell you that before the testing is done. The first step is a comprehensive developmental and binocular vision evaluation, which identifies what is causing the problem, whether vision therapy is indicated at all, and what the plan, timeline and cost would be for that specific patient.
Schedule an evaluation or read more about what our examinations include.
Common Questions About This Topic
How much does vision therapy cost?
At our offices most sessions fall in the $110 to $200 range, depending on whether the session is 30 or 45 minutes. Our binocular vision and visual processing programs usually run about 18 to 24 weeks; amblyopia, strabismus and brain injury programs often take longer, with one to three sessions per week, so the total depends far more on the length and intensity of the program than on the per-session fee. The most accurate estimate comes after the evaluation, once we know what is being treated and what schedule is recommended.
Why does the price vary so much between patients?
Session length, visits per week, total program length, how much home practice actually gets done, and the treatment goals all change the structure of care. A child with symptomatic convergence insufficiency and good home follow-through may need a very different plan than an adult recovering from a concussion. The published trials had a fixed protocol because they were research; real programs are matched to the patient.
How many sessions did the research programs use?
In the Convergence Insufficiency Treatment Trial, the office-based group had a weekly 60-minute in-office visit for 12 weeks plus 15 minutes of prescribed home therapy 5 days a week. The follow-on CITT-ART trial ran the same office-based therapy over 16 weeks. Those figures are a useful benchmark when you are comparing what one practice recommends against another.
Does insurance cover vision therapy?
Sometimes in part. We are an out-of-network practice and payment is due at the time of service. Some patients submit for reimbursement using their out-of-network benefits and we provide the documentation. Coverage depends entirely on your plan, deductible, coinsurance, visit limits, exclusions and documentation requirements, so call your carrier before you begin.
Can I use HSA or FSA funds, a payment plan or financial help?
Many families do use HSA or FSA funds when their plan permits it, and it is worth confirming eligibility with your benefits administrator first. We also accept major cards, checks, cash and CareCredit, offer structured payment plans that can extend beyond the therapy timeline, and give a 5-10% discount on the therapy session portion to families who pay in full. We also award scholarships to two patients each month, and for eligible families we accept Step Up for Students (Unique Abilities Scholarship) under the terms listed on our pricing page.
Where This Information Comes From
- Convergence Insufficiency Treatment Trial Study Group (2008). Randomized clinical trial of treatments for symptomatic convergence insufficiency in children. Archives of Ophthalmology, 126(10):1336-1349. : 221 children aged 9-17 randomized to four arms; the office-based vergence/accommodative arm ran 12 weeks of weekly 60-minute in-office therapy visits plus prescribed home therapy 15 minutes a day, 5 days a week, and the two home-based therapies were no more effective at improving symptoms than office-based placebo therapy.
- Scheiman M, Kulp MT, Cotter SA, Lawrenson JG, Wang L, Li T (2020). Interventions for convergence insufficiency: a network meta-analysis. Cochrane Database of Systematic Reviews, 12:CD006768. : Across 12 trials and 1,289 participants, office-based vergence/accommodative therapy with home reinforcement was about three times as likely as placebo to produce a successful outcome in children (RR 3.04); adult evidence is less clear.
- CITT-ART Investigator Group (2019). Effect of Vergence/Accommodative Therapy on Reading in Children with Convergence Insufficiency: A Randomized Clinical Trial. Optometry and Vision Science, 96(11):836-849. : In 310 children, reading comprehension improved 3.7 points with 16 weeks of office-based therapy versus 3.8 points with placebo therapy; no reading benefit over placebo.
- Scheiman M, Mitchell GL, Cotter S, et al. (2005). A randomized clinical trial of vision therapy/orthoptics versus pencil pushups for the treatment of convergence insufficiency in young adults. Optometry and Vision Science, 82(7):583-595. : In 46 adults aged 19-30, symptom-elimination criteria were met by 42% with office-based therapy versus 31% with placebo, and more than half of treated adults remained symptomatic.
- Chang MY, Morrison DG, Binenbaum G, et al. (2021). Home- and Office-Based Vergence and Accommodative Therapies for Treatment of Convergence Insufficiency in Children and Young Adults: A Report by the American Academy of Ophthalmology. Ophthalmology, 128(12):1756-1765. : Level I evidence supports office-based therapy for improving motor outcomes in children with symptomatic CI; results on symptom relief are inconsistent, evidence for home-based therapies is insufficient, and in young adults office-based therapy was not superior to placebo for symptoms.
- Singh A, Saxena V, Yadav S, et al. (2021). Comparison of home-based pencil push-up therapy and office-based orthoptic therapy in symptomatic patients of convergence insufficiency: a randomized controlled trial. International Ophthalmology, 41(4):1327-1336. : In 176 patients aged 9-30 with compliance tracked by logbook, home pencil push-ups and office-based synoptophore therapy produced similar improvement in near point of convergence and symptoms, though office therapy gave better fusional vergence; there was no placebo arm.
- Holmes JM, Manh VM, Lazar EL, et al.; Pediatric Eye Disease Investigator Group (2016). Effect of a Binocular iPad Game vs Part-time Patching in Children Aged 5 to 12 Years With Amblyopia: A Randomized Clinical Trial. JAMA Ophthalmology, 134(12):1391-1400. : Only 22.2% of children assigned a prescribed home treatment completed more than 75% of it, illustrating how far home adherence can fall below what is prescribed.
Care We Provide
More From the Blog
Wondering If This Sounds Like Your Family?
A developmental vision evaluation measures the skills a routine eye exam does not. Our team sees children and adults in Coconut Creek, Boynton Beach, Boca Raton and West Palm Beach.